Work

First-in-human data of ALLO-501 and ALLO-647 in relapsed/refractory large B-cell or follicular lymphoma (R/R LBCL/FL): ALPHA study.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.8002

Authors: Sattva Swarup Neelapu, Javier Munoz, Frederick Lundry Locke, David Bernard Miklos, Robert Brown, Jennifer T. McDevitt, Armen Mardiros, Eren Demirhan, Cyril Konto, Michael Timothy Tees

Institutions: The University of Texas MD Anderson Cancer Center, Banner MD Anderson Cancer Center, Moffitt Cancer Center, Stanford Medicine, Stanford University, Allogene Therapeutics (United States), Colorado Blood Cancer Institute

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3030827170

Cites:

Cited by: 46

Related to: 10